Genetic epidemiology of Trypanosoma cruzi infection and Chagas' disease

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Williams Blangero, Sarah ^a   VandeBerg, John L ^a,b   Blangero, John ^a   Corrêa Oliveira, Rodrigo ^c  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Genome scan; Human population studies; Linkage analysis; Pedigrees; Quantitative genetic analysis; Review

Indexed keywords

CHAGAS DISEASE; DISEASE MODEL; DISEASE SEVERITY; FAMILY STUDY; GENE CONTROL; GENETIC EPIDEMIOLOGY; GENETIC RISK; HEREDITY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INSECT CONTROL; MEDICAL RESEARCH; NONHUMAN; PARASITE VECTOR; PEDIGREE; PHENOTYPE; REVIEW; RISK FACTOR; SOUTH AND CENTRAL AMERICA; TRYPANOSOMIASIS; VARIANCE; ZOONOSIS;

ANIMALIA; ARTHROPODA; INSECTA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 3142715344     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. McNicholl J.M. & K.T. Cuenco: Host genes and infectious diseases. HIV, other pathogens, and public health perspective. Am J Prev Med 16, 141-154 (1999)
2. Williams-Blangero S., J.L. VandeBerg, & J. Blangero: Genetic epidemiology of parasitic diseases. In: N. Mascie-Taylor, ed. Frontiers in Human Health, Cambridge, Cambridge University Press (In press)
3. Abel L., F. Demanais, A. Prata, A.E. Souza, & A. Dessain: Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 48, 959-970 (1991)
4. Abel L., M. Cot, L. Mulder, O.P. Carnevale, & J. Feingold: Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am J Hum Genet 50, 1308-1317 (1992)
5. Garcia A., L. Abel, M. Cot, P. Richard, S. Ranque, J. Feingold, F. Demanais, M. Boussinesq, & J.P. Chippaux: Genetic epidemiology of host predisposition to microfilaremia in human loiasis. Trop Med Int Health 4, 565-574 (1999)
6. Williams-Blangero S., J. Blangero, & M. Bradley: Quantitative genetic analysis of susceptibility to hookworm infection in a population from rural Zimbabwe. Hum Biol 69, 201-208 (1997)
7. Williams-Blangero S., J. Subedi, R.P. Upadhayay, D.P. Manral, D.R. Rai, B. Jha, E.S. Robinson, & J. Blangero: Genetic analysis of susceptibility to infection with Ascaris lumbricoides. Am J Trop Med Hyg 60, 921-926 (1999)
8. Williams-Blangero S., S.T. McGarvey, J. Subedi, P.M. Wiest, R.P. Upadhayay, D.R. Rai, B. Jha, G.R. Olds, W. Guanling, & J. Blangero: Genetic component to susceptibility to Trichuris trichiura: Evidence from two Asian populations. Genet Epidemiol 22, 254-264 (2002)
9. Williams-Blangero S., J.L. VandeBerg, J. Subedi, M.J. Aivaliotis, D.R. Rai, R.P. Upadhayay, B. Jha, & J. Blangero: Genes on chromosomes land 13 have significant effects on Ascaris infection. Proc Natl Acad Sci, US 8, 5533-5538 (2002)
10. Marquet S., L. Abel, D. Hillaire, H. Dessein, J. Kalil, J. Feingold, J. Weissenbach, & A.J. Dessein: Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nature Genetics 14, 181-184 (1996)
11. Schofield C.J. & J.C.P. Dias: The Southern Cone initiative against Chagas' disease. Adv Parasitol 42:1-27 (1999)
12. Tanowitz H.B., S.A. Morris, S.M. Factor, L.M. Weiss, & M. Wittner: Parasitic disease of the heart I: Acute and chronic Chagas Disease. Cardiovascular Pathology 1, 7-15 (1992)
13. Kirchoff L.V.: American trypanosomiasis (Chagas Disease) Gastroenterology Clinics North Amer 25, 517-533 (1996)
14. Tanowitz H.B., L.V. Kirchhoff, D. Simon, S.A. Morris, L.M. Weiss, & M. Wittner: Chagas' disease. Clin Microbiol Rev 5, 400-419 (1992)
15. WHO: Chagas Disease: Tropical Diseases, Tropical Disease research Progress, 1991-1992. Eleventh Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Geneva: World Health Organization, 67-75, (1993)
16. WHO: Chagas disease. Weekly Epidemiological Record 72, 1-4 (1997)
17. WHO: Chagas disease, Venezuela, 1999. Weekly Epidemiological Record 35, 290-292 (1999)
18. Kelly J.M.: A B-cell activator in Chagas disease. Nat Med 6, 865-866 (2000)
19. World Bank: World Development Report 1993 (1993)
20. Rothhammer F., M.J. Allison, L. Nunez, V. Standen, & B. Arriaza: Chagas' disease in pre-Columbian South America. Am J Phys Anthropol 68:495-498 (1985)
21. Coimbra, C.E.A.: Human settlements, demographic pattern, and epidemiology in lowland Amazonia: The case of Chagas' disease. Am Anthropol 90, 82-97 (1988)
22. Guhl F., C. Jaramillo, G.A. Vallejo, R. Yockteng, F. Cardenas-Arroyo, G. Fornaciari, B. Arriaza, & A.C. Aufderheide: Isolation of Trypanosoma cruzi DNA in 4,000-year-old mummified human tissue from northern Chile Am J Phys Anthropol 108, 401-407 (1999)
23. Ferreira L.F., C. Britto, M.A. Cardoso, O. Fernandes, K. Reinhard, & A. Araujo: Paleoparasitology of Chagas disease revealed by infected tissues from Chilean mummies. Acta Trop 75, 79-84 (2000)
24. Kollien A.H. & G.A. Schaub: The development of Trypanosoma cruzi in Triatominae. Parasitol Today 16, 381-387 (2000)
25. Coura J.R., A.C. Junqueira, M.N. Boia, & O. Fernandes: Chagas disease: From bush to huts and houses. Is it the case of the Brazilian Amazon? Mem Inst Oswaldo Cruz 94 (Suppl 1), 379-384 (1999)
26. Coura J.R., A.C. Junqueira, M.N. Boia, O. Fernandes, C. Bonfante, J.E. Campos, L. Santos, & R. Devera: Chagas disease in the Brazilian Amazon. IV. A new cross-sectional study. Rev Inst Med Trop S Paulo 44, 159-165 (2002)
27. Albarracin-Veizaga H., M.E. de Carvalho, E.M. Nascimento, V.L. Rodrigues, C. Casanova, & J.M. Barata: Chagas disease in an area of recent occupation in Cochabamba, Bolivia. Rev Saude Publica 33, 230-236 (1999)
28. Dias-Lima A.G. & I.A. Sherlock: Sylvatic vectors invading houses and the risk of emergence of cases of Chagas disease in Salvador, State of Bahia, Northeast Brazil. Mem Inst Oswaldo Cruzi 95, 611 -613 (2000)
29. Vassena C.V., M.I. Picollo, & E.N. Zerba: Insecticide resistance in Brazilian Triatoma infestans and Venezuelan Rhodnius prolixus. Med Vet Entomol 14, 51-55 (2000)
30. Zerba E.N.: Susceptibility and resistance to insecticides of Chagas disease vectors. Medicina (B Aires) 59(S2), 41-46 (1999)
31. Kinnamon K.E., B.T. Poon, W.L. Hanson, & V.B. Waits: In pursuit of drugs for American trypanosomiasis: Evaluation of some "standards" in a mouse model. Proc Soc Exp Biol Med 216, 424-428 (1997)
32. Fairlamb A.H.: Future prospects for the chemotherapy of Chagas Disease. Medicina (B Aires) 59(Suppl. 2), 179-187 (1999)
33. Stoppani A.O.: The chemotherapy of Chagas Disease. Medicine (B Aires) 59(Suppl. 2), 147-165 (1999)
34. Nogueira N. & J.R. Coura: 1990 American trypanosomiasis (Chagas' disease) In: Tropical and Geographical Medicine. Eds: Warren K.S. & A.A.F. Mahmoud, McGraw-Hill, New York, New York, 281-296 (1990)
35. Neva F.A.: American trypanosomiasis (Chagas' disease) In: L. Goldman & J.C. Bennett, eds. Cecil Textbook of Medicine. Philadelphia, W.B. Saunders. Pp. 1954-1958 (2000)
36. Morris S.A., H.B. Tanowitz, M. Wittner, & J.P. Bilezikian: Pathophysiological insights into the cardiomyopathy of Chagas Disease. Circulation 82, 1900-1909 (1990)
37. Maguire J.H., R. Hoff, I. Sherlock, A.C. Guimaraes, A.C. Sleigh, N.B. Ramos, K.E. Mott, & T.H. Weller: Cardiac morbidity and mortality due to Chagas' disease: Prospective electrocardiographic study of a Brazilian community. Circulation 75, 1140-1145 (1987)
38. Sgambatti de Andrade A.L.S., F. Zicker, A. Rassi, A.G. Rassi, R.M. Oliveira, S.A. Silva, S. Sgambatti de Andrade, & C.M.T. Martelli: Early electrocardiographic abnormalities in Trypanosoma cruzi-seropositive children. Am J Trop Med Hyg 59:530-534 (1998)
39. Lazarri J.O., M. Oereira, C.M.F. Antunes, A. Guimaraes, A. Moncayo, R.C. Dominguez, O.H. Pieretti, V. Macedo, A. Rassi, J. Maguire, & A. Romero: Diagnostic electrocardiography in epidemiological studies of Chagas' disease: Multicenter evaluation of a standardized method. Pan Am J Public Health 4, 317-330 (1998)
40. Samudio M., S. Montenegro-James, M. Cabral, J. Martinez, A.R. Arias, O. Woroniecky, & M.A. James: Differential expression of systemic cytokine profiles in Chagas' disease is associated with endemicity of Trypanosoma cruzi infections. Acta Tropica 69, 89-97 (1998)
41. Rezende J.M. Clinica manifestacoes digestivas. In: Z. Brener and Z. Andrade, eds. Trypanosoma cruzi e Doenca de Chagas. Rio de Janeiro, Guanabara Koogan. P. 312 (1979)
42. Oliveira R.B. de, J. Rezende Filho, R.O. Dantas, & N. Iazigi: The spectrum of esophageal motor disorders in Chagas' disease. Am J Gastroenterol 90, 119-1124 (1995)
43. Dantas R.O., N.H. Deghaide, & E.A. Donadi: Esophageal manometric and radiologic findings in asymptomatic subjects with Chagas' disease. J Clin Gastroenterol 28, 245-248 (1999)
44. Dias J.C.P.: The indeterminate form of human chronic Chagas Disease: A clinical epidemiological review. Rev Soc Bras Med Trop 22, 147-156 (1989)
45. + lymphocytes. Am J Trop Med Hyg 43, 637-644 (1993)
46. Reis D.D., E.M. Jones, S. Tosets, E.R. Lopes, E. Chapadeiro, G. Gazzinelli, D.G. Colley, & T. McCurley: Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas Disease. Am J Trop Med Hyg 49, 192-199 (1993)
47. Abel L.C.J., L.V. Rizzo, B. Ianni, F. Albuquerque, F. Bacal, D. Carrara, E.A. Bocchi, H.C. Teixeira, C. Mady, J. Kalil, & E. Cunha-Neto: Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmunity 17, 99-108 (2001)
48. Soares M.B.P., K.N. Silva-Mota, R.S. Lima, M.C. Bellintani, L. Pontes-de-Carvalho, & R. Ribeiro-dos-Santos: Modulation of Chagasic cardiomyopathy by interleukin-4: Dissociation between inflammation and tissue parasitism. Am J Pathol 159, 703-709 (2001)
49. Zhang L. & R.L. Tarleton: Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infec Dis 180, 480-486 (2001)
50. Bahia-Oliveira L.M., J.A. Gomes, M.O. Rocha, M.C. Moreira, E.M. Lemos, Z.M. Luz, M.E. Pereira, R.L. Coffman, J.C. Dias, J.R. Cancado, G. Gazinnelli, & R. Correa-Oliveira: IFN-gamma in human Chagas' disease: Protection or pathology? Bras J Med Biol Res 31, 127-131 (1998)
51. Corrêa-Oliveira R., J. Gomes, E.M. Lemos, G.M. Cardosa, D.D. Reis, S. Adad, E. Crema, O.A. Martins-Filho, M.O. Costa, G. Gazzinelli, & L.M. Bahia-Oliveira: The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz 94, 253-255 (1999)
52. Tarleton R.L. & L. Zhang: Chagas disease etiology: Autoimmunity or parasite persistence? Parasitol Today 15, 94-99 (1999)
53. Vago A.R., L.O. Andrade, A.A. Leite, D. Reis d'Avila, A.M. Macedo, S.J. Adad, S. Tostes Jr., M.C. Moreira, G.B. Filho, & S.D. Pena: Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: Differential distribution of genetic types into diverse organs. Am J Pathol 156, 1805-1809 (2000)
54. Vago A.R., A.M. Macedo, S.J. Adad, D.D. Reis, & R. Correa-Oliveira: PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet 348, 891-892 (1996)
55. Cunha-Neto E., M. Duranti, A. Gruber, B. Zingales, I. De Messias, N. Stolf, G. Belloti, M.E. Patarroyo, F. Pillegi, & J. Kallil: Autoimmunity in Chagas disease cardiopathy: Biological relevance of caridac myosin specific epitope cross reactive to immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci, USA 92:3541-3545 (1995)
56. Martins-Filho O.A., M.E.S. Pereira, J.F. Carvalho, J.R. Cancado, & Z. Brener: Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas Disease. Clin Diag Lab Immunol 2, 569-573 (1995)
57. Morgan J., J.C. Dias, E.D. Gontijo, L. Bahia-Oliveira, R. Corrêa-Oliveira, D.G. Colley, & Powell M.R.: Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg 55, 355-9 (1996)
58. Cordeiro F.D., O.A. Martins-Filho, M.O.C. Rocha, S.J. Adad, R. Corrêa-Oliveira, & A.J. Romanha: Anti-trypanosoma cruzi IgG1 can be a useful tool for the diagnosis and prognosis of human Chagas' disease. Clin Diag Lab Immunol (In Press)
59. Jones E.M., D.G. Colley, S. Tostes, E.R. Lopes, C.L. Vnencak-Jones, T.L. McCurley: Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48, 348-357 (1993)
60. Tibayrenc M.: Integrated genetic epidemiology of infectious diseases: The Chagas= model. Mem Inst Oswaldo Cruz 93, 577-580 (1998)
61. Tibayrenc M.: Toward an integrated genetic epidemiology of parasitic protozoa and other pathogens. Annu Rev Genet 33, 449-477 (1999)
62. Feitosa M.F. & H. Krieger: A model for intra-familial distribution of an infectious disease (Chagas' disease) Mem Inst Oswaldo Cruz 88:231-233 (1993)
63. Zicker F., P.G. Smith, J.C.A. Netto, R.M. Oliveira, & E.M.S. Zicker: Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas' cardiopathy. Am J Trop Med Hyg 43, 498-505 (1990)
64. Morini J.C., H. Berra, H.O. Davila, J.F. Pividori, & O.A. Bottasso: Electrocardiographic alteration among first degree relatives with serologic evidence of Trypanosoma cruzi infection. A sibship study. Mem Inst Oswaldo Cruz 89, 371-375 (1994)
65. Teixeira A.R.L.: 1979 Chagas' disease: Trends in immunological research and prospects for immunoprophylaxis. Bull World Hlth Org 57, 697-710 (1979)
66. Nieto A., Y. Beraun, M.D. Collado, A. Caballero, A. Alonso, A. Gonzalez, & J. Martin: HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 55, 195-198 (2000)
67. Fernandes-Mestre M.T., Z. Layrisse, S. Montagnani, H. Acquatella, F. Catalioti, M. Matos, O. Balbas, N. Makhatadze, E. Dominguez, F. Herrera, & A. Madrigal: Influence of the HLA class II polymorphism in chronic Chagas Disease. Parasite Immunol 20, 197-203 (1998)
68. Deghaide N.H.S., R.O. Dantes, & E.A. Donadi: HLA class I and class II profiles of patients presenting with Chagas Disease. Dig Dis Sci 43, 246 (1998)
69. Llop W.R., F. Rothhammer, M. Acuña, & W. Apt: HLA antigens in cardiomyopathic Chilean Chagasics. Am J Hum Genet 43, 770-773 (1988)
70. Colorado I.A., H. Acquatella, F. Catalioti, M.T. Fernandez & Z. Layrisse: HLA class II DRB1, DPB1polymorphisms and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum Immunol. 61, 320-325 (2000)
71. Layrisse Z., M.T. Fernandez, S. Montagnani, M. Matos, O. Balbas, F. Herrera, I.A. Colorado, F. Catalioti, & H. Acquatella: HLA-C*03 is a risk factor for cardiomyopathy in Chagas disease. Hum Immunol 61, 925-929 (2000)
72. Fae K.C., S.A. Drigo, E. Cunha-Neto, B. Ianni, C. Mady, J. Kalil, & A.C. Goldberg. HLA and beta-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy. Microbes Infect 2, 745-751 (2000)
73. Acquatella H., F. Catalioti, J.R. Gomez, C. Piccone-Oseroff, & Z. Layrisse: Asociación entre HLA-DB9 y enfermedad de Chagas. In: V. Rodriguez-Lemoine (ed): Genética: VI Congreso Latinoamericano de Genética. Maracaibo, Venezuela: Ars. Gráfica S.A., 328 (1984)
74. Terwilliger J.D. & K.M. Weiss: Linkage disequilibrium mapping of complex disease: Fantasy or reality? Curr Opin Biotechnol 9, 578-594 (1998)
75. Blangero J., J.T. Williams, & L. Almasy: Quantitative trait locus mapping using human pedigrees. Hum Biol. 72, 35-62 (2000)
76. Dyer T.D., J. Blangero, J.T. Williams, H.H. Goring, & M.C. Mahaney: The effect of pedigree complexity on quantitative trait linkage analysis. Genet Epidemiol 21, S236-S243 (2001)
77. Barbosa C.A.A., N.E. Morton, D.C. Pao, & H. Krieger: Biological and cultural determinants of immunoglobulin levels in a Brazilian population with Chagas' disease. Hum Genet 59, 161-163 (1981)
78. Williams-Blangero S., J.L. VandeBerg, J. Blangero & A.R.L. Teixeira: Genetic epidemiology of seropositivity for T. cruzi infection in rural Goiás, Brazil. Am J Trop Med Hyg 57, 538-543 (1997)
79. Lander E.S. & N.J. Schork: Genetic dissection of complex traits. Science 265(5181), 2037-2048 (1994)
80. Blangero J.: Statistical genetic approaches to human adaptability. Hum Biol 65, 941-966 (1993)
81. Blangero J.: Multivariate oligogenic linkage analysis of quantitative traits in general pedigrees. Am J Hum Genet 57:A11 (1995)
82. Almasy L. & J. Blangero: Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211 (1998)
83. Hanis C.L., E. Boerwinkle, R. Chakraborty, D.L. Ellsworth, P. Concannon, B. Stirling, V.A. Morrison, B. Wapelhorst, R.S. Spielman, K.J. Gogolin-Ewens, J.L. Shepard, S.R. Williams, N. Risch, D. Hinds, N. Iwasaki, M. Ogata, Y. Omori, C. Petzold, H. Rietzch, H.E. Schroder, J. Schilze, N.J. Cox, S. Menzel, V.V. Boriraj, X. Chen & G. Bell: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2 Nat Genet 13, 161-166 (1996)
84. Hanson R.L., M.G. Ehm, D.J. Pettitt, M. Prochazka, D.B. Thompson, D. Timberlake, T. Foroud, S. Kobes, L. Baier, D.K. Burns, L. Almasy, J. Blangero, W.T. Garvey, P.H. Bennett, & W.C. Knowler: An autosomal genomic scan for loci linked to Type 2 diabetes mellitus and body mass index in Pima Indians: An obesity-diabetes locus at 11q23-25. Am J Hum Genet 63, 1130-1138 (1998)
85. Duggirala R.D., J. Blangero, B.D. Mitchell, L. Almasy, T.D. Dyer, R.J. Leach, P. O'Connell, & M.P. Stern: Linkage of Type 2 diabetes mellitus and age of diabetes onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 64, 1127-1140 (1999)
86. Comuzzie A.G., J.E. Hixson, L. Almasy, B.D. Mitchell, M.C. Mahaney, T.D. Dyer, M.P. Stern, J.W. MacCluer, & J. Blangero: A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 15, 273-275 (1997)
87. Duggirala R., M.P. Stern, B.D. Mitchell, L.J. Reinhart, P.A. Shipman, O.C. Uresandi, W.K. Chung, R.L. Leibel, C.N. Hales, P. O'Connell, & J Blangero: Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet 59, 694-703 (1996)
88. Reich T., H.J. Edenberg, A. Goate, J.T. Williams, J.P. Rice, P. Van Eerdewegh, T. Foroud, V. Hesselbrock, M.A. Shuckit, K. Bucholz, B. Porjesz, T.K. Li, M. Conneally, J.I. Nurnberger Jr., J.A. Tischfield, R.R. Crowe, C.R. Cloninger, W. Wu, S. Shears, K. Carr, C. Crose, C. Willig, & H. Begleiter: Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 81, 207-215 (1998)
89. Begleiter H., B. Porjesz, T. Reich, H. Edenberg, A. Goate, J. Blangero, P. van Eerdewegh, T. Foroud, A. Litke, D. Chorlian, L. Almasy, J. Rorhbaugh, S. O'Connor, L. Bauer, S. Juperman, J. Polich, J. Rice, V. Hesselbrock, T.K. Li, M. Conneally, M. Shuckit, R. Cloninger, J. Nurnberger, R. Crowe, & F. Bloom: Quantitative trait linkage analysis of human event-related brain potentials: P3 voltage. Electroencephalogr Clin Neurophysiol 108, 244-250 (1998)
90. Williams J.T., H. Begleiter, B. Porjesz, H.J. Edenberg, T. Foroud, T. Reich, A. Goate, P. Van Eerdewegh, L. Almasy, & J. Blangero: Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. II. Alcoholism and event-related potentials. Am J Hum Genet 65, 1148-1160 (1999)
91. Ohlstein E.H., R.R. Ruffolo, Jr., & J.D. Elliott: Drug discovery in the next millennium. Annu Rev Pharmacol Toxicol 40:177-191 (2000)
92. Browne M.J., I. Gloger, J.E. Hodgson, & J.H. Robinson: The importance of genome analysis to the drug discovery process. Molec Med Today 1, 373-377 (1995)
93. Gelbert L.M. & R.E. Gregg: Will genetics really revolutionize the drug discovery process? Curr Opinion Biotechnol 8, 669-674 (1997)